Should I buy or sell Bausch Health Companies stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" BHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BHC, but not buy additional shares or sell existing shares. View BHC analyst ratings or view top-rated stocks .

What is Bausch Health Companies' stock price target for 2024?

1 brokers have issued 1 year price targets for Bausch Health Companies' shares. Their BHC share price targets range from C$8.00 to C$8.00. On average, they anticipate the company's stock price to reach C$8.00 in the next twelve months. This suggests that the stock has a possible downside of 19.4%. View analysts price targets for BHC or view top-rated stocks among Wall Street analysts .

How have BHC shares performed in 2023?

Bausch Health Companies' stock was trading at C$8.50 at the beginning of the year. Since then, BHC stock has increased by 16.8% and is now trading at C$9.93. View the best growth stocks for 2023 here .

When is Bausch Health Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024. View our BHC earnings forecast .

How were Bausch Health Companies' earnings last quarter?

Bausch Health Companies Inc. (TSE:BHC) released its quarterly earnings data on Thursday, November, 2nd. The company reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.23 by $0.15. The firm earned $3 billion during the quarter, compared to analysts' expectations of $2.96 billion. Bausch Health Companies had a negative net margin of 11.27% and a negative trailing twelve-month return on equity of 983.84%.

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Chesapeake Energy (CHKAQ) , Enbridge (ENB) , Aurora Cannabis (ACB) , Manulife Financial (MFC) , BlackBerry (BB) , Bank of Nova Scotia (BNS) , Toronto-Dominion Bank (TD) , Nutrien (NTR) , Suncor Energy (SU) and ARC Resources (ARX) .

How do I buy shares of Bausch Health Companies?

Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

Bausch Health Companies Stock Price, News & Analysis (TSE:BHC)

C$9.93

+0.25 (+2.58%)

(As of 12/1/2023 ET)

Compare

Today's Range: C$9.61
▼
C$9.95
50-Day Range: C$9.02
▼
C$11.26
52-Week Range: C$7.56
▼
C$13.81

Volume: 257,551 shs
Average Volume: 458,309 shs
Market Capitalization: C$3.63 billion

P/E Ratio: N/A
Dividend Yield: 0.76%
Price Target: C$8.00

Stock Analysis Analyst Forecasts Chart Competitors Earnings Headlines Insider Trades

Bausch Health Companies MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 19.4% Downside
C$8.00 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.13 out of 5 stars

1.0

Analyst's Opinion

Consensus Rating
Bausch Health Companies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$8.00, Bausch Health Companies has a forecasted downside of 19.4% from its current price of C$9.93.
Amount of Analyst Coverage
Bausch Health Companies has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for BHC.

0.0

Dividend Strength

Dividend Yield
Bausch Health Companies has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Bausch Health Companies does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BHC.

1.9

News and Social Media Coverage

News Sentiment
Bausch Health Companies has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Bausch Health Companies this week, compared to 2 articles on an average week.
Search Interest
35 people have searched for BHC on MarketBeat in the last 30 days. This is an increase of 59% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bausch Health Companies insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 7.86% of the stock of Bausch Health Companies is held by insiders.
Percentage Held by Institutions
74.12% of the stock of Bausch Health Companies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Bausch Health Companies is -2.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Bausch Health Companies is -2.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Bausch Health Companies has a PEG Ratio of 0.21. PEG Ratios below 1 indicate that a company could be undervalued.

See Top Rated MarketRank™ Stocks Here

About Bausch Health Companies Stock (TSE:BHC)

Bausch Health Companies Inc. operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. was incorporated in 2013 and is headquartered in Laval, Canada.

BHC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BHC Stock News Headlines

November 30, 2023 | finance.yahoo.com

Is Bausch Health (BHC) Stock Outpacing Its Medical Peers This Year?

November 24, 2023 | finance.yahoo.com

Wall Street Analysts Believe Bausch (BHC) Could Rally 38.28%: Here's is How to Trade

December 1, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 21, 2023 | finance.yahoo.com

Is Bausch + Lomb Corporation (NYSE:BLCO) Trading At A 39% Discount?

November 13, 2023 | finance.yahoo.com

UnitedHealth (UNH) Unit Makes Insulin More Affordable to Avail

November 13, 2023 | finance.yahoo.com

Bausch (BHC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

November 10, 2023 | finance.yahoo.com

The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis

November 3, 2023 | msn.com

Bausch Health (BHC) Q3 Earnings & Sales Beat, '23 View Updated

December 1, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 2, 2023 | finance.yahoo.com

Bausch + Lomb Corporation (NYSE:BLCO) Q3 2023 Earnings Call Transcript

November 2, 2023 | marketwatch.com

Bausch Health Scales Up Revenue Guidance for 2023

November 2, 2023 | finance.yahoo.com

Bausch Health Companies Inc (BHC) Reports 9% Revenue Growth in Q3 2023

November 2, 2023 | finance.yahoo.com

Bausch (BHC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

November 2, 2023 | finanznachrichten.de

Bausch Health Companies Inc.: Bausch Health Announces Third-Quarter 2023 Results

November 2, 2023 | finance.yahoo.com

Bausch Health Announces Third-Quarter 2023 Results

October 26, 2023 | finanznachrichten.de

Bausch Health Companies Inc.: Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder

October 26, 2023 | finance.yahoo.com

Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)

October 20, 2023 | finanznachrichten.de

Bausch Health Companies Inc.: FDA Approves Cabtreo Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older

October 20, 2023 | msn.com

Bausch Health gets FDA approval for acne treatment Cabtreo

October 20, 2023 | finance.yahoo.com

FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older

October 4, 2023 | finanznachrichten.de

Bausch Health Companies Inc.: Salix Pharmaceuticals Partners with Bellamy Young

October 4, 2023 | finance.yahoo.com

Salix Pharmaceuticals Partners with Bellamy Young

September 26, 2023 | finance.yahoo.com

Lyon Dance Biennale has an experimental and inclusive year — review

September 23, 2023 | businesswire.com

BAUSCH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bausch Health Companies, Inc. and Encourages Investors ...

September 21, 2023 | 247wallst.com

Thursday's Top Analyst Upgrades and Downgrades: Bausch Health, Disney, IBM, Kimco Realty, Pinterest, Western Digital and More

September 21, 2023 | finance.yahoo.com

Strength Seen in Bausch (BHC): Can Its 8.0% Jump Turn into More Strength?

September 21, 2023 | finance.yahoo.com

League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease

See More Headlines

Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/02/2023
Today: 12/01/2023
Next Earnings (Estimated): 2/22/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: TSE:BHC
CUSIP: N/A
CIK: N/A
Web: www.valeant.com
Phone: 514-744-6792
Fax: N/A
Employees: 19,900
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: C$8.00
High Stock Price Target: C$8.00
Low Stock Price Target: C$8.00
Potential Upside/Downside: -19.4%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($3.61)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 1.85
P/E Growth: 0.21
Net Income: C$-963,000,000.00
Net Margins: -11.27%
Pretax Margin: N/A
Return on Equity: -983.84%
Return on Assets: 3.61%

Debt

Debt-to-Equity Ratio: 7,583.76
Current Ratio: 1.20
Quick Ratio: 0.58

Sales & Book Value

Annual Sales: C$8.54 billion
Price / Sales: 0.42
Cash Flow: C$1.28 per share
Price / Cash Flow: 7.76
Book Value: C($3.23) per share
Price / Book: -3.07

Miscellaneous

Outstanding Shares: 365,200,000
Free Float: N/A
Market Cap: C$3.63 billion
Optionable: Not Optionable
Beta: 0.98

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Thomas J. Appio (Age 61)
CEO & Director
Comp: $6.48M
Ms. Seana Carson (Age 51)
Executive VP & General Counsel
Comp: $986.61k
Mr. John S. Barresi (Age 50)
Senior VP, Controller, Chief Accounting Officer & Interim CFO
Mr. Mirza Dautbegovic
Senior VP & COO
Mr. Josh Coyle
Senior Vice President of Sales & Salix
Ms. Kathleen Fitzpatrick
Senior VP & Chief HR Officer
Dr. Tage Ramakrishna M.D. (Age 49)
Chief Medical Officer and President of R&D
Mr. Jeff Hartness
Executive VP of Market Access, Commercial Operations, Neurology, Generics & Government Affairs
Dr. Graham Jackson
Senior VP & Chief Quality Officer
Mr. Cees Heiman
Senior Vice President of Europe & Canada

Key Competitors

View All Competitors

BHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Bausch Health Companies stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" BHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BHC, but not buy additional shares or sell existing shares.
View BHC analyst ratings or view top-rated stocks.
What is Bausch Health Companies' stock price target for 2024?: 1 brokers have issued 1 year price targets for Bausch Health Companies' shares. Their BHC share price targets range from C$8.00 to C$8.00. On average, they anticipate the company's stock price to reach C$8.00 in the next twelve months. This suggests that the stock has a possible downside of 19.4%.
View analysts price targets for BHC or view top-rated stocks among Wall Street analysts.
How have BHC shares performed in 2023?: Bausch Health Companies' stock was trading at C$8.50 at the beginning of the year. Since then, BHC stock has increased by 16.8% and is now trading at C$9.93.
View the best growth stocks for 2023 here.
When is Bausch Health Companies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our BHC earnings forecast.

How were Bausch Health Companies' earnings last quarter?: Bausch Health Companies Inc. (TSE:BHC) released its quarterly earnings data on Thursday, November, 2nd. The company reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.23 by $0.15. The firm earned $3 billion during the quarter, compared to analysts' expectations of $2.96 billion. Bausch Health Companies had a negative net margin of 11.27% and a negative trailing twelve-month return on equity of 983.84%.
What other stocks do shareholders of Bausch Health Companies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Enbridge (ENB), Aurora Cannabis (ACB), Manulife Financial (MFC), BlackBerry (BB), Bank of Nova Scotia (BNS), Toronto-Dominion Bank (TD), Nutrien (NTR), Suncor Energy (SU) and ARC Resources (ARX).
How do I buy shares of Bausch Health Companies?: Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:BHC) was last updated on 12/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bausch Health Companies Stock Price, News & Analysis (TSE:BHC)

Bausch Health Companies MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Bausch Health Companies Stock (TSE:BHC)

BHC Stock Price History

BHC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

BHC Stock Analysis - Frequently Asked Questions

Overall MarketRank^™